Literature DB >> 11508390

Clinical features of vivax malaria.

M D Oh1, H Shin, D Shin, U Kim, S Lee, N Kim, M H Choi, J Y Chai, K Choe.   

Abstract

Plasmodium vivax malaria reemerged in the Republic of Korea in 1993 near the Demilitarized Zone (DMZ). We reviewed clinical features of 101 symptomatic patients with vivax malaria. Of the patients, 77 patients (76.3%) were veterans who had served near the DMZ; their median age was 23 years. The duration of the minimum latent period was > 6 months in 66.2% (51 of 77) of the patients (median, 278 days). Tertian fever developed in 69 patients (68.3%). Severe thrombocytopenia with platelet counts < 60,000/microL was common (29.6% of patients). The parasite densities ranged 32-52,127 parasites per microliter of blood (geometric mean, 1,287). The only complication was a splenic rupture in one patient. All patients responded promptly to chloroquine therapy. Our data suggest that the clinical features of reemerging vivax malaria may be similar to those of Korean vivax malaria reported in the past.

Entities:  

Mesh:

Year:  2001        PMID: 11508390     DOI: 10.4269/ajtmh.2001.65.143

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Prevention and treatment of vivax malaria.

Authors:  J Kevin Baird; Eli Schwartz; Stephen L Hoffman
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

2.  Acute surgical abdomen: an atypical presentation of Plasmodium vivax malaria.

Authors:  Sunil Gopisetty; Jonahan Sarveswaran; Raj Achuthan; J Davies; J R Ausobsky
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

Review 3.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

4.  A case of symptomatic splenic infarction in vivax malaria.

Authors:  Areum Kim; Yun-Kyu Park; Jin-Soo Lee; Moon-Hyun Chung; Eun Sil Kim
Journal:  Korean J Parasitol       Date:  2007-03       Impact factor: 1.341

Review 5.  Evidence and implications of mortality associated with acute Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

6.  Malaria Surveillance - United States, 2017.

Authors:  Kimberly E Mace; Naomi W Lucchi; Kathrine R Tan
Journal:  MMWR Surveill Summ       Date:  2021-03-19

7.  Parasitemia characteristics of Plasmodium vivax malaria patients in the Republic of Korea.

Authors:  Ae-Jung Huh; Yee Gyung Kwak; Eu Suk Kim; Kkot Sil Lee; Joon-Sup Yeom; Yong-Kyun Cho; Chang-Seok Kim; Jae-Won Park
Journal:  J Korean Med Sci       Date:  2010-12-22       Impact factor: 2.153

8.  Risk analysis of the re-emergence of Plasmodium vivax malaria in Japan using a stochastic transmission model.

Authors:  Tomoyuki Bitoh; Kaoru Fueda; Hiroshi Ohmae; Mamoru Watanabe; Hirofumi Ishikawa
Journal:  Environ Health Prev Med       Date:  2010-10-26       Impact factor: 3.674

9.  Rapid diagnosis of vivax malaria by the SD Bioline Malaria Antigen test when thrombocytopenia is present.

Authors:  Sei Won Lee; Kyeongman Jeon; Byung Ryul Jeon; Inho Park
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

10.  Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia.

Authors:  Desta Kassa; Beyene Petros; Tsehaynesh Mesele; Ermias Hailu; Dawit Wolday
Journal:  Clin Vaccine Immunol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.